Correlation Between Eyebright Medical and New China

Can any of the company-specific risk be diversified away by investing in both Eyebright Medical and New China at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyebright Medical and New China into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eyebright Medical Technology and New China Life, you can compare the effects of market volatilities on Eyebright Medical and New China and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyebright Medical with a short position of New China. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyebright Medical and New China.

Diversification Opportunities for Eyebright Medical and New China

0.83

Correlation Coefficient

Eyebright Medical  New China

Very poor diversification

The 3 months correlation between Eyebright and New is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Eyebright Medical Technology and New China Life in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on New China Life and Eyebright Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyebright Medical Technology are associated (or correlated) with New China. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of New China Life has no effect on the direction of Eyebright Medical i.e., Eyebright Medical and New China go up and down completely randomly.

Pair Corralation between Eyebright Medical and New China

Assuming the 90 days trading horizon Eyebright Medical Technology is expected to under-perform the New China. In addition to that, Eyebright Medical is 1.15 times more volatile than New China Life. It trades about -0.02 of its total potential returns per unit of risk. New China Life is currently generating about 0.06 per unit of volatility. If you would invest  4,642  in New China Life on September 29, 2024 and sell it today you would earn a total of  417.00  from holding New China Life or generate 8.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Eyebright Medical Technology  vs.  New China Life

Eyebright Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eyebright Medical Technology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Eyebright Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

New China Life

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in New China Life are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, New China may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Eyebright Medical and New China

The main advantage of trading using opposite Eyebright Medical and New China positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyebright Medical position performs unexpectedly, New China can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in New China will offset losses from the drop in New China's long position.

The idea behind Eyebright Medical Technology and New China Life pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.